Sugi Predict

Sugi Predict / Compounds / SCHEMBL623740

SCHEMBL623740

SCHEMBL623740

COC(=O)c1sc(N)c(C#N)c1C

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.71
▸ ALDH1A1 P00352 8/20 0.63
▸ MAPK1 P28482 2/20 0.63
▸ TSHR P16473 1/20 0.63
▸ HSD17B10 Q99714 1/20 0.63
▸ HPGD P15428 2/20 0.56
▸ MAPT P10636 4/20 0.54
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ CISD2 Q8N5K1 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.50
▸ GAA P10253 1/20 0.49
▸ RXFP1 Q9HBX9 2/20 0.48
▸ LMNA P02545 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ VCP P55072 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ APOBEC3G Q9HC16 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3050182 0.86 ADORA2A (0.55) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL626630 0.85 ADORA2A (0.74) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL1622788 0.84 ADORA2A (0.60) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL18430437 0.82 ALDH1A1 (0.50) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL1313857 0.82 ALDH1A1 (0.62) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL11746774 0.82 ALDH1A1 (0.62) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL10876508 0.82 ALDH1A1 (0.62) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL10917274 0.82 ADORA2A (0.52) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL28353428 0.81 CISD2 (0.58) ADORA2AALDH1A1MAPK1TSHRHSD17B10
SCHEMBL10508850 0.80 ADORA2A (0.49) ADORA2AALDH1A1MAPK1TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118496197-A Substituted thiophenecarboxamides, thiophenecarboxylic acids and derivatives thereof 拜耳公司 2024-08-16 — — CN disclosed
EP-4285723-A2 SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF Bayer Aktiengesellschaft (DE) 2023-12-06 — — EP disclosed
CN-113831337-B GLP-1 receptor agonist, and pharmaceutical composition and use thereof 广州市恒诺康医药科技有限公司 2023-03-24 — — CN disclosed
CN-110724136-B Amide compound and preparation method and application thereof 沈阳中化农药化工研发有限公司 2023-02-17 — — CN disclosed
US-20230046892-A1 SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2023-02-16 — — US disclosed
CN-115103840-A Substituted thiophenecarboxamides, thiophenecarboxylic acids and derivatives thereof 拜耳公司 2022-09-23 — — CN disclosed
WO-2021259309-A1 GLP-1 RECEPTOR AGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 广州市恒诺康医药科技有限公司 2021-12-30 — — WO disclosed
CN-113831337-A GLP-1 receptor agonist, and pharmaceutical composition and use thereof 广州市恒诺康医药科技有限公司 2021-12-24 — — CN disclosed
WO-2021123051-A1 SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2021-06-24 — — WO disclosed
CN-110724136-A Amide compound and preparation method and application thereof 沈阳中化农药化工研发有限公司 2020-01-24 — — CN disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 — — WO disclosed
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2011-11-10 — — US disclosed
EP-2375899-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF Array Biopharma, Inc. (US) 2011-10-19 — — EP disclosed
US-20110212103-A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-01 — — US disclosed
US-20110212103-A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-01 — — US disclosed
US-20110212103-A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-01 — — US disclosed
WO-2011104340-A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-01 — — WO disclosed
WO-2010080864-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF ARRAY BIOPHARMA INC. (US) 2010-07-15 — — WO disclosed
US-4263205-A FOR COLORING POLYMERS, LACQUERS CIBA-GEIGY CORPORATION (US) 1981-04-21 — — US disclosed
US-3998802-A POLYAMIDES, CELLULOSE ESTERS, POLYESTERS, POLYACRYLONITRILES BASF AKTIENGESELLSCHAFT (DT) 1976-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230046892-A1 SUBSTITUTED THIOPHENE CARBOXAMIDES, THIOPHENE CARBOXYLIC ACIDS AND DERIVATIVES THEREOF PGLS, TST, TPI1 ADORA2A 4127/4885ALDH1A1 2521/4885MAPK1 3002/4885
US-20110275608-A1 PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF NOS1, NOS2, ASS1 ADORA2A 1664/4885ALDH1A1 28/4885MAPK1 313/4885
US-20110212103-A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS CMPK1, DTYMK, NEK2 ADORA2A 1056/4885ALDH1A1 3994/4885MAPK1 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.